← Back to All US Stocks

AAWH Stock Analysis - Ascend Wellness Holdings, Inc. AI Rating

AAWH OTC Medicinal Chemicals & Botanical Products DE CIK: 0001756390
Analysis Date: Mar 18, 2026 | Data as of: 2025-12-31
AI Rating
STRONG SELL
92% Confidence

Investment Thesis

Ascend Wellness is in acute financial distress with negative stockholders' equity of -$47.4M, indicating liabilities exceed assets by a significant margin. The company is experiencing deteriorating profitability with net margins of -23.6%, negative operating income of -$17.0M, and an alarming -$118.2M net loss, while revenue is contracting at -10.9% YoY. Although operating cash flow of $38.1M provides temporary liquidity, the negative equity position, high debt burden of $319.5M, and inability to cover interest obligations signal imminent solvency risk.

AAWH Strengths

  • + Positive operating cash flow of $38.1M provides near-term liquidity cushion
  • + Current ratio of 1.92x indicates adequate short-term liquidity relative to current liabilities
  • + Gross margin of 33.9% shows underlying business units can generate adequate margins on direct costs

AAWH Risks

  • ! Negative stockholders' equity of -$47.4M represents technical insolvency and existential balance sheet risk
  • ! Net loss of -$118.2M with -23.6% net margin indicates severe operational unprofitability and cash burn
  • ! Long-term debt of $319.5M with negative interest coverage ratio of -0.3x means company cannot service debt from earnings
  • ! Revenue decline of -10.9% YoY combined with operating losses suggests deteriorating market position
  • ! Zero insider buying activity in last 90 days indicates lack of management confidence in turnaround

Key Metrics to Watch

AAWH Financial Metrics

Revenue
$500.6M
Net Income
$-118.2M
EPS (Diluted)
$-0.58
Free Cash Flow
$12.0M
Total Assets
$907.9M
Cash Position
$85.7M

AAWH Profitability Ratios

Gross Margin 33.9%
Operating Margin -3.4%
Net Margin -23.6%
ROE N/A
ROA -13.0%
FCF Margin 2.4%

AAWH Balance Sheet & Liquidity

Current Ratio
1.92x
Quick Ratio
1.14x
Debt/Equity
N/A
Debt/Assets
105.1%
Interest Coverage
-0.33x
Long-term Debt
$319.5M
Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 18, 2026 | Data as of: 2025-12-31 | Powered by Claude AI